Post-earnings recap
Reported
Tue, Aug 6, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio-Techne Corp's earnings report showed a slight miss on EPS, which contributed to a 2.68% decline in stock price. The lack of revenue data and guidance may have left investors uncertain about the company's short-term outlook. However, management's focus on innovation suggests they are positioning for future growth despite current challenges.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.25 | N/A | -7.04% |
Overall, management conveyed a cautious optimism about future opportunities despite missing EPS expectations. They emphasized their commitment to innovation.
Management highlighted ongoing investments in innovation and product development.
They acknowledged current market challenges but expressed confidence in long-term growth.